Business Context and Reporting Period
Company: Fresenius Medical Care AG & Co. KGaA
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Month of October 2017
Document Date: October 27, 2017
Principal Executive Offices: Bad Homburg, Germany
Financial Metrics
The provided filing text does not contain specific financial data. This Form 6-K serves as a cover document referencing a press release (Exhibit 99.1) but does not include the text of that release or any tables detailing revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The filing text does not provide information regarding material changes versus prior periods. The content is limited to the form's administrative header, exhibit listing, and signature block.
Guidance, Outlook, and Risks
No guidance, outlook, management commentary, risks, contingencies, or unusual items are described in the provided text. The document indicates that a press release was issued on October 27, 2017, but the substance of that release is not included in the input.
Key Facts for Investor Verification
- The filing is a procedural Form 6-K referencing an external press release (Exhibit 99.1) rather than a standalone financial report.
- Specific financial results for October 2017 are not present in this text; investors must locate the full text of the October 27, 2017 press release.
- The report is signed by Rice Powell (CEO) and Michael Brosnan (CFO) of the General Partner.
- The registrant files annual reports under Form 20-F.